1
|
Cozzi A, Pinker K, Hidber A, Zhang T, Bonomo L, Lo Gullo R, Christianson B, Curti M, Rizzo S, Del Grande F, Mann RM, Schiaffino S, Panzer A. BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study. Radiology 2024; 311:e232133. [PMID: 38687216 PMCID: PMC11070611 DOI: 10.1148/radiol.232133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Revised: 03/08/2024] [Accepted: 03/12/2024] [Indexed: 05/02/2024]
Abstract
Background The performance of publicly available large language models (LLMs) remains unclear for complex clinical tasks. Purpose To evaluate the agreement between human readers and LLMs for Breast Imaging Reporting and Data System (BI-RADS) categories assigned based on breast imaging reports written in three languages and to assess the impact of discordant category assignments on clinical management. Materials and Methods This retrospective study included reports for women who underwent MRI, mammography, and/or US for breast cancer screening or diagnostic purposes at three referral centers. Reports with findings categorized as BI-RADS 1-5 and written in Italian, English, or Dutch were collected between January 2000 and October 2023. Board-certified breast radiologists and the LLMs GPT-3.5 and GPT-4 (OpenAI) and Bard, now called Gemini (Google), assigned BI-RADS categories using only the findings described by the original radiologists. Agreement between human readers and LLMs for BI-RADS categories was assessed using the Gwet agreement coefficient (AC1 value). Frequencies were calculated for changes in BI-RADS category assignments that would affect clinical management (ie, BI-RADS 0 vs BI-RADS 1 or 2 vs BI-RADS 3 vs BI-RADS 4 or 5) and compared using the McNemar test. Results Across 2400 reports, agreement between the original and reviewing radiologists was almost perfect (AC1 = 0.91), while agreement between the original radiologists and GPT-4, GPT-3.5, and Bard was moderate (AC1 = 0.52, 0.48, and 0.42, respectively). Across human readers and LLMs, differences were observed in the frequency of BI-RADS category upgrades or downgrades that would result in changed clinical management (118 of 2400 [4.9%] for human readers, 611 of 2400 [25.5%] for Bard, 573 of 2400 [23.9%] for GPT-3.5, and 435 of 2400 [18.1%] for GPT-4; P < .001) and that would negatively impact clinical management (37 of 2400 [1.5%] for human readers, 435 of 2400 [18.1%] for Bard, 344 of 2400 [14.3%] for GPT-3.5, and 255 of 2400 [10.6%] for GPT-4; P < .001). Conclusion LLMs achieved moderate agreement with human reader-assigned BI-RADS categories across reports written in three languages but also yielded a high percentage of discordant BI-RADS categories that would negatively impact clinical management. © RSNA, 2024 Supplemental material is available for this article.
Collapse
Affiliation(s)
| | | | - Andri Hidber
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Tianyu Zhang
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Luca Bonomo
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Roberto Lo Gullo
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Blake Christianson
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Marco Curti
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Stefania Rizzo
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | - Filippo Del Grande
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| | | | | | - Ariane Panzer
- From the Imaging Institute of Southern Switzerland (IIMSI), Ente
Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B.,
M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology,
Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.);
Faculty of Biomedical Sciences, Università della Svizzera Italiana,
Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology,
Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.);
Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen,
the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and
Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.)
| |
Collapse
|